ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
High-tech radiotherapy, drug combinations and immunotherapy showcased as future of cancer treatment - The Institute of Cancer Research, London
ICR Postdoc Association (PDA) (@Postdocs_ICR) / Twitter
Professor Kevin Harrington - The Institute of Cancer Research, London
The ICR on Twitter: "ICR's Professor Kevin Harrington speaks about the @NICEcomms news about immunotherapy #nivolumab https://t.co/pRd7KUmAmR #CancerDrugsFund https://t.co/ompikxJVHr" / Twitter
Statement about NICE decision on T-VEC for treating inoperable metastatic melanoma | The Royal Marsden
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Scientists reveal new lines of attack to raise cancer survival rate | Cancer research | The Guardian
The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
BBC Two - Trust Me, I'm a Doctor, Series 3, Episode 3 - Could viral immunotherapy be a revolution in cancer treatment?
Get A-Head Visit The Institute of Cancer Research - Get Ahead
Connections blog - ICR celebrates innovation and commercialisation at staff awards - The Institute of Cancer Research, London
ICR calls for improved biomarker cancer tests to help personalise treatment - PMLiVE
The ICR on Twitter: "Today, Prof. Kevin Harrington (ICR/@cancerBRC) will present on a trial of RP2, a first-in-class, enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody as a single agent and combined
Cancer survival 'to double in 10 years' - PressReader
Scientific Lecture | Kevin Harrington | FRONTAL
The ICR on Twitter: "🧬 The ICR's Professor Kevin Harrington and his team are using viral #Immunotherapy to harness the body's immune system to kill cancer. See their research with T-VEC, a
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Cancer: Scientists aim to double survival within a decade | The Independent
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
